
July 15, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector continues its momentum
July 15, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector continues its momentum
July 15, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector continues its momentum
July 15, 2024
RegMed Investors (RMi) Research note: LENZ Therapeutics (LENZ +$0.16 to $21.19 at open) $30 M PIPE financing
July 15, 2024
RegMed Investors’ (RMi) pre-open: Uncle algo and his electronic trading dwarfs are thirstin’ for some on-base profits
July 14, 2024
RegMed Investors (RMi) Closing Bell: share pricing slides into home plate in the week
July 12, 2024
RegMed Investors’ (RMi) pre-open: batting, waiting for the pitch
July 11, 2024
RegMed Investors (RMi) Closing Bell: still on the mound, strike 1 after morning post and waiting for the second pitch
July 11, 2024
RegMed Investors (RMi) Closing Bell: still on the mound, strike 1 after morning post and waiting for the second pitch
July 11, 2024
RegMed Investors’ (RMi) pre-open: warning, an overbought sector
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors